The inhibitory receptor Fc␥RIIb is a negative regulator of antibody production and inflammatory responses. The ؊343 G 3 C polymorphism in the human FCGR2B promoter is associated with systemic lupus erythematosus. The ؊343 C mutant promoter has decreased transcriptional activity. In the present study, we show that the transcriptional change correlates with quantitative differences in the interaction of the activating protein 1 complex with the mutant FCGR2B promoter. Promoter pulldown and chromatin immunoprecipitation assays demonstrated binding of c-Jun to the FCGR2B promoter. Phosphorylation of c-Jun was accompanied by transactivation of both FCGR2B promoter variants, whereas dephosphorylation of c-Jun by an inhibitor of c-Jun N-terminal kinase, markedly decreased the promoter activities. The ؊343 G 3 C substitution enabled the specific interaction of the transcription factor YinYang 1 with the mutant FCGR2B promoter. Yin-Yang 1 competed with activating protein 1 for binding at the ؊343 site, and contributed to the repression of the mutant FCGR2B promoter activity. This mechanism could be responsible for the decreased expression of Fc␥RIIb associated with the ؊343 C/C homozygous FCGR2B genotype in lupus patients. These findings provide a rationale for the transcriptional defect mediated by the ؊343 C/C FCGR2B promoter polymorphism associated with systemic lupus erythematosus, and add to our understanding of the complex transcriptional regulation of the human FCGR2B promoter.Fc ␥-receptors (Fc␥R) 2 bind IgG-containing immune complexes and mediate important immune functions such as phagocytosis, degranulation, antibody-dependent cellular cytotoxicity, and production of inflammatory mediators. Human hematopoetic cells express several Fc␥R isoforms encoded by seven separate genes. Unlike activating Fc␥R, Fc␥RIIb is unique in that it contains an immunoreceptor tyrosine-based inhibitory motif in the intracellular domain. A specific amino acid sequence in the immunoreceptor tyrosine-based inhibitory motif domain of Fc␥RIIb allows the recruitment of phosphatases and the initiation of inhibitory signaling. Cross-linking of Fc␥RIIb with activating receptors on B cells and mononuclear phagocytes leads to down-regulation of antibody production, phagocytosis, and cytokine secretion. Several lines of evidence demonstrate that Fc␥RIIb is important in the maintenance of self-tolerance. Fc␥RIIb deficiency is associated with spontaneous development of autoimmune manifestations in several mouse genetic backgrounds (1). Autoimmune prone mouse strains share an Fcgr2 promoter haplotype containing deletions and polymorphisms associated with reduced expression of Fc␥RIIb on the surface of activated B cells and macrophages (2-4). Whereas the engineered deletion and the natural deficiency in Fc␥RIIb confer susceptibility to development of lupus-like disease, transplantation of bone marrow cells transduced with Fc␥RIIb-expressing retrovirus restored the healthy phenotype (5). This body of data created the impetus for the study of Fc␥RIIb...